Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015 by Laut, Kamilla, Shepherd, Leah, Radoi, Roxana, Karpov, Igor, Parczewski, Milosz, Mussini, Cristina, Maltez, Fernando, Losso, Marcelo, Chkhartishvili, Nikoloz, Elinav, Hila, Kovari, Helen, Blaxhult, Anders, Zangerle, Robert, Trofimova, Tatiana, Inglot, Malgorzata, Zilmer, Kai, Kuzovatova, Elena, Staub, Thérèse, Raben, Dorthe, Lundgren, Jens, Mocroft, Amanda, Kirk, Ole, On Behalf Of The EuroSIDA Study Group

Get full text

Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe by Santos, JR, Cozzi‐Lepri, A, Phillips, A, De Wit, S, Pedersen, C, Lazzarin, A, Sluzhynska, M, Orkin, C, Duvivier, C, Bogner, J, Gargalianos‐Kakolyris, P, Schmid, P, Hassoun, G, Khromova, I, Beniowski, M, Sedlacek, D, Paredes, R, Lundgren, JD, Losso, M, Zangerle, R, Vassilenko, A, Paduto, D, Clumeck, N, Delforge, M, Florence, E, Vandekerckhove, L, Begovac, J, Machala, L, Jilich, D, Benfield, T, Ostergaard, L, Ristola, M, Viard, J.‐P, Girard, P.‐M, Rockstroh, J, Schmidt, R, Degen, O, Stellbrink, H. J, Stefan, C, Sambatakou, H, Szlávik, J, Mulcahy, F, Yust, I, Sthoeger, Z. M, D'Arminio Monforte, A, Mussini, C, Mazzotta, F, Vullo, V, Zaccarelli, M, Antinori, A, Acinapura, R, Plazzi, M, Gianotti, N, Galli, M, Ridolfo, A, Matulionyte, R, Staub, T, Bruun, J, Gasiorowski, J, Pynka, M, Mularska, E, Gensing, M, Jablonowska, E, Mansinho, K, Maltez, F, Radoi, R, Panteleev, A, Panteleev, O, Trofimora, T, Borodulina, E, Vdoushkina, E, Gatell, J. M, Moreno, S, Rodriguez, J. M, Clotet, B, Tural, C, Puig, J, Bravo, I, Mateo, G, Sambeat, M. A, Thalme, A, Cavassini, M, Calmy, A, Furrer, H, Battegay, M, Kuznetsova, A, Kyselyova, G, Simons, E, Edwards, S, Johnson, M. A, Mocroft, A, Weber, J, Clarke, A, Gatell, J, Matthews, C, Fischer, A. H, Raben, D, Grønborg Laut, K, Larsen, J. F, Schultze, A

Get full text

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study by VAN LUIN, Matthijs, BANNISTER, Wendy P, LUNDGREN, Jens D, BURGER, David M, MOCROFT, Amanda, REISS, Peter, DI PERRI, Giovanni, PEYTAVIN, Gilles, MOLTO, José, KARLSON, Anders, CASTAGNA, Antonella, BENIOWSKI, Marek

Get full text

Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study by CABRERA, Cecilia, COZZI-LEPRI, Alessandro, CLOTET, Bonaventura, RUIZ, Lidia, PHILLIPS, Andrew N, LOVEDAY, Clive, KIRK, Ole, AITKHALED, Mounir, REISS, Peter, KJOER, Jesper, LEDERGERBER, Bruno, LUNDGREN, Jens D

Get full text

P19 Response to second‐line protease‐inhibitor (PI) regimens: results from the EuroSIDA study by Mocroft, A, Phillips, An, Miller, V, Gatell, J, Van Lunzen, J, Lazzarin, A, On, Jd Lundgren, Of, Behalf, Group, The EuroSida Study

Get full text